Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Clinical trial NCT06934382 · RECRUITING
Trial details
- NCT number
- NCT06934382
- Sponsor
- Stephan Grupp MD PhD
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-29
- Primary completion
- 2029-05-30
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.